Predicting mortality risk for people 75 and older admitted to the ICU.
Official title: Development of a Predictive Model for Mortality in Patients Aged 75 or Older With Critical Illness
Run by Consorci Sanitari de l'Alt Penedès i Garraf · NCT06727903 · Data updated 2026-11-12
This project tries to use lab biomarker data to predict which people aged 75 and older admitted from the emergency department to the ICU are most likely to die.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf Academic / other |
| Locations | 14 sites (Badalona, Barcelona and 13 other locations) |
| Status | Recruiting |
| Started | March 20, 2025 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06727903 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and women aged 75 or older who are admitted from the Emergency Department to one of the participating ICUs and can provide consent or have a legal representative and an informant available.
✕Probably not a fit
Patients who are younger than 75, transferred from hospital wards, admitted to step-down units, die within the first 24 hours, or who required advanced resuscitation before ED arrival are unlikely to benefit from this model.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study that collects laboratory biomarker data at ICU admission and links it with clinical information to build a predictive model of in-hospital mortality for very elderly patients. Participants are adults aged 75 or older admitted from the emergency department to participating ICUs, with consent obtained from the patient or a legal representative and an available informant. Patients transferred from wards, admitted to step-down units, or who die within 24 hours of ICU admission are excluded. The model development will use data from multiple hospitals in the Barcelona area to derive and potentially internally validate risk predictions.
Why it matters
Potential benefit: If successful, the model could help clinicians identify high-risk older ICU patients earlier, guiding monitoring, treatment priorities, and timely goals-of-care conversations.
How similar studies have gone: Previous ICU mortality prediction tools (eg, APACHE, SAPS, SOFA) and some biomarker-based models have shown moderate success, but models specifically developed and validated for very elderly ICU populations remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women aged 75 or older. * Admission to an ICU from the Emergency Department. * Availability of or possibility to contact a participant's informant. * Informed consent for participation in the study, either by the participant or a valid legal representative. Exclusion Criteria: Participants meeting any of the following exclusion criteria will not be included in the study: * Patients transferred to the Emergency Department from a hospital ward. * Patients who die within the first 24 hours of ICU admission. * Patients admitted to Step-Down Units. * Patients requiring ICU admission for any of the following reasons: Orotracheal intubation or advanced cardiopulmonary resuscitation performed prior to arrival at the Emergency Department. AV block awaiting pacemaker implantation. Activation of the STEMI or Stroke care pathway. Post-cardiac catheterization for acute coronary syndrome. * Participation in another clinical study involving an intervention, procedure, or visit schedule that is incompatible with the present study.
Where it's running
-
Hospital German Trias i Pujol
Badalona, Barcelona, Spain Recruiting -
Consorci Sanitari Alt Penedès-Garraf
Sant Pere de Ribes, Barcelona, Spain Recruiting -
Hospital Clinic
Barcelona, Spain Recruiting -
Hospital de Barcelona
Barcelona, Spain Recruiting -
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting -
Hospital de Mataró
Barcelona, Spain Recruiting
Show 8 more locations
-
Hospital de Terrassa
Barcelona, Spain Recruiting -
Hospital del Mar
Barcelona, Spain Recruiting -
Hospital Dexeus Barcelona
Barcelona, Spain Recruiting -
Hospital General de Catalunya
Barcelona, Spain Recruiting -
Hospital Sagrat Cor
Barcelona, Spain Recruiting -
Clinica Girona
Girona, Spain Recruiting -
Hospital General de Granollers
Barcelona, Spain Not yet recruiting -
Hospital Santa Caterina
Girona, Spain Not yet recruiting
Study contacts
- Study coordinator: César Gálvez, Ph.D.
- Email: cgalvez@csapg.cat
- Phone: +34 9389600325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.